Major Shareholder Warburg Pincus Sells $229M in Sotera Health Stock
Summary
Warburg Pincus & Co., a Director and 10% Owner, sold 15 million shares of Sotera Health common stock for $229.05 million as part of a secondary offering.
Key Events
-
Significant Insider Sale
Warburg Pincus & Co., a Director and 10% Owner, sold 15 million shares of Sotera Health common stock.
-
Substantial Proceeds
The sale generated $229.05 million in proceeds for Warburg Pincus.
-
Part of Secondary Offering
This transaction is part of the secondary offering of 25 million shares by major institutional shareholders, which was finalized on March 5, 2026.
-
Follows GTCR Sale
This filing follows a similar Form 4 from GTCR affiliates on March 10, 2026, which detailed their sale of 10 million shares in the same offering.
Analysis
This Form 4 details Warburg Pincus & Co.'s participation in the recently completed secondary offering, where they disposed of a substantial portion of their holdings. The sale of 15 million shares, valued at over $229 million, represents a significant reduction in their stake in Sotera Health. This follows the earlier Form 4 from GTCR affiliates, another major shareholder, detailing their portion of the same offering. While the overall secondary offering was previously announced, these Form 4 filings provide specific transaction details from key institutional investors, confirming their partial exit and adding to the overall distribution signal.
At the time of this filing, SHC was trading at $14.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4B. The 52-week trading range was $9.53 to $19.85. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.